Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0K6BI
|
||||
Former ID |
DIB019412
|
||||
Drug Name |
compound 2c
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [531713] | ||
Structure |
Download2D MOL |
||||
Formula |
C11H9Br4N3O2
|
||||
InChI |
InChI=1S/C11H9Br4N3O2/c1-17(2)11-16-9-7(14)5(12)6(13)8(15)10(9)18(11)3-4(19)20/h3H2,1-2H3,(H,19,20)
|
||||
InChIKey |
PHAOTASRLQMKBE-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | casein kinase 2, alpha prime polypeptide subunit | Target Info | Inhibitor | [531713] | |
Casein kinase II, alpha chain | Target Info | Inhibitor | [531713] | ||
NetPath Pathway | FSH Signaling Pathway | ||||
Pathway Interaction Database | BCR signaling pathway | ||||
Atypical NF-kappaB pathway | |||||
DNA-PK pathway in nonhomologous end joining | |||||
Presenilin action in Notch and Wnt signaling | |||||
Role of Calcineurin-dependent NFAT signaling in lymphocytes | |||||
E-cadherin signaling in the nascent adherens junction | |||||
Lissencephaly gene (LIS1) in neuronal migration and development | |||||
PDGFR-alpha signaling pathway | |||||
Signaling mediated by p38-alpha and p38-beta | |||||
Alpha-synuclein signaling | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.